AI-identified histologic feature may offer ‘prognostic value,’ inform care in colon cancer

A prognostic study validated the use of an artificial intelligence-derived tumor adipose feature, which may aid risk stratification of colon cancer and provide prognostic value when integrated into practice, according to study results.“Prognostic markers are of significant clinical interest in colorectal cancer, as some patients with stage II disease may benefit from adjuvant chemotherapy, and, for patients with stage III disease, improved prognostic information can inform treatment regimen and duration,” Vincenzo L’Imperio, MD, assistant professor of pathology at theRead More